Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 162
Filter
1.
J Neurogenet ; 32(3): 256-266, 2018 09.
Article in English | MEDLINE | ID: mdl-30303018

ABSTRACT

Little is known about the molecular underpinning of behavioral pleiotropy. The Drosophila melanogaster foraging gene is highly pleiotropic, affecting many independent larval and adult phenotypes. Included in foraging's multiple phenotypes are larval foraging path length, triglyceride levels, and food intake. foraging has a complex structure with four promoters and 21 transcripts that encode nine protein isoforms of a cGMP dependent protein kinase (PKG). We examined if foraging's complex molecular structure underlies the behavioral pleiotropy associated with this gene. Using a promotor analysis strategy, we cloned DNA fragments upstream of each of foraging's transcription start sites and generated four separate forpr-Gal4s. Supporting our hypothesis of modular function, they had discrete, restricted expression patterns throughout the larva. In the CNS, forpr1-Gal4 and forpr4-Gal4 were expressed in neurons while forpr2-Gal4 and forpr3-Gal4 were expressed in glia cells. In the gastric system, forpr1-Gal4 and forpr3-Gal4 were expressed in enteroendocrine cells of the midgut while forpr2-Gal4 was expressed in the stem cells of the midgut. forpr3-Gal4 was expressed in the midgut enterocytes, and midgut and hindgut visceral muscle. forpr4-Gal4's gastric system expression was restricted to the hindgut. We also found promoter specific expression in the larval fat body, salivary glands, and body muscle. The modularity of foraging's molecular structure was also apparent in the phenotypic rescues. We rescued larval path length, triglyceride levels (bordered on significance), and food intake of for0 null larvae using different forpr-Gal4s to drive UAS-forcDNA. In a foraging null genetic background, forpr1-Gal4 was the only promoter driven Gal4 to rescue larval path length, forpr3-Gal4 altered triglyceride levels, and forpr4-Gal4 rescued food intake. Our results refine the spatial expression responsible for foraging's associated phenotypes, as well as the sub-regions of the locus responsible for their expression. foraging's pleiotropy arises at least in part from the individual contributions of its four promoters.


Subject(s)
Cyclic GMP-Dependent Protein Kinases/genetics , Drosophila Proteins/genetics , Feeding Behavior/physiology , Genetic Pleiotropy/genetics , Animals , Drosophila melanogaster , Larva , Phenotype , Promoter Regions, Genetic/genetics
2.
Am J Physiol Regul Integr Comp Physiol ; 314(2): R282-R293, 2018 02 01.
Article in English | MEDLINE | ID: mdl-29118020

ABSTRACT

Homeostatic regulation of visceral organ function requires integrated processing of neural and neurohormonal sensory signals. The nucleus of the solitary tract (NTS) is the primary sensory nucleus for cranial visceral sensory afferents. Angiotensin II (ANG II) is known to modulate peripheral visceral reflexes, in part, by activating ANG II type 1A receptors (AT1AR) in the NTS. AT1AR-expressing NTS neurons occur throughout the NTS with a defined subnuclear distribution, and most of these neurons are depolarized by ANG II. In this study we determined whether AT1AR-expressing NTS neurons receive direct visceral sensory input, and whether this input is modulated by ANG II. Using AT1AR-GFP mice to make targeted whole cell recordings from AT1AR-expressing NTS neurons, we demonstrate that two-thirds (37 of 56) of AT1AR-expressing neurons receive direct excitatory, visceral sensory input. In half of the neurons tested (4 of 8) the excitatory visceral sensory input was significantly reduced by application of the transient receptor potential vallinoid type 1 receptor agonist, capsaicin, indicating AT1AR-expressing neurons can receive either C- or A-fiber-mediated input. Application of ANG II to a subset of second-order AT1AR-expressing neurons did not affect spontaneous, evoked, or asynchronous glutamate release from visceral sensory afferents. Thus it is unlikely that AT1AR-expressing viscerosensory neurons terminate on AT1AR-expressing NTS neurons. Our data suggest that ANG II is likely to modulate multiple visceral sensory modalities by altering the excitability of second-order AT1AR-expressing NTS neurons.


Subject(s)
Neurons, Afferent/metabolism , Receptor, Angiotensin, Type 1/metabolism , Solitary Nucleus/metabolism , Angiotensin II/pharmacology , Animals , Genes, Reporter , Glutamic Acid/metabolism , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Membrane Potentials , Mice, Transgenic , Nerve Fibers, Myelinated/metabolism , Nerve Fibers, Unmyelinated/metabolism , Neurons, Afferent/drug effects , Promoter Regions, Genetic , Receptor, Angiotensin, Type 1/agonists , Receptor, Angiotensin, Type 1/genetics , Solitary Nucleus/cytology , Solitary Nucleus/drug effects , Synaptic Transmission
3.
Am J Physiol Regul Integr Comp Physiol ; 313(4): R438-R449, 2017 Oct 01.
Article in English | MEDLINE | ID: mdl-28701322

ABSTRACT

Angiotensin II acts via two main receptors within the central nervous system, with the type 1A receptor (AT1AR) most widely expressed in adult neurons. Activation of the AT1R in the nucleus of the solitary tract (NTS), the principal nucleus receiving central synapses of viscerosensory afferents, modulates cardiovascular reflexes. Expression of the AT1R occurs in high density within the NTS of most mammals, including humans, but the fundamental electrophysiological and neurochemical characteristics of the AT1AR-expressing NTS neurons are not known. To address this, we have used a transgenic mouse, in which the AT1AR promoter drives expression of green fluorescent protein (GFP). Approximately one-third of AT1AR-expressing neurons express the catecholamine-synthetic enzyme tyrosine hydroxylase (TH), and a subpopulation of these stained for the transcription factor paired-like homeobox 2b (Phox2b). A third group, comprising approximately two-thirds of the AT1AR-expressing NTS neurons, showed Phox2b immunoreactivity alone. A fourth group in the ventral subnucleus expressed neither TH nor Phox2b. In whole cell recordings from slices in vitro, AT1AR-GFP neurons exhibited voltage-activated potassium currents, including the transient outward current and the M-type potassium current. In two different mouse strains, both AT1AR-GFP neurons and TH-GFP neurons showed similar AT1AR-mediated depolarizing responses to superfusion with angiotensin II. These data provide a comprehensive description of AT1AR-expressing neurons in the NTS and increase our understanding of the complex actions of this neuropeptide in the modulation of viscerosensory processing.


Subject(s)
Neurons/metabolism , Receptor, Angiotensin, Type 1/metabolism , Solitary Nucleus/metabolism , Animals , Female , Green Fluorescent Proteins/metabolism , Male , Mice , Mice, Transgenic , Neurons/cytology , Patch-Clamp Techniques , Promoter Regions, Genetic , Receptor, Angiotensin, Type 1/genetics , Solitary Nucleus/cytology , Tyrosine 3-Monooxygenase/metabolism
4.
Respir Physiol Neurobiol ; 226: 147-51, 2016 06.
Article in English | MEDLINE | ID: mdl-26593642

ABSTRACT

Sympathetic nerve activity to the cardiovascular system displays prominent respiratory-related modulation which leads to the generation of rhythmic oscillations in blood pressure called Traube-Hering waves. An amplification of this respiratory modulation of sympathetic activity is observed in hypertension of both genetic, the spontaneously hypertensive rat, and induced, chronic intermittent hypoxia or maternal protein restriction during gestation, origin. Male offspring of mothers with uteroplacental insufficiency, induced by bilateral uterine vessel ligation at 18 days of gestation, are also hypertensive in adulthood. In this study we examined whether these male offspring display altered respiratory modulation of sympathetic activity at pre-hypertensive ages compared to controls. Respiratory, cardiovascular and sympathetic parameters were examined using the working heart-brainstem preparation in 35 day old male rats that had reduced birth weight due to uteroplacental insufficiency. Whilst all respiratory parameters were not different between groups, we observed an enhanced respiratory-related burst of thoracic sympathetic nerve activity and amplified Traube-Hering waves in the growth-restricted group. This group also showed an increased sympathetic and bradycardic response to activation of peripheral chemoreceptors. The observations add support to the view that altered respiratory modulation of sympathetic activity represents a common mechanism involved in the development of several forms of hypertension.


Subject(s)
Fetal Hypoxia/physiopathology , Fetal Nutrition Disorders/physiopathology , Respiration , Sympathetic Nervous System/physiopathology , Animals , Bradycardia/physiopathology , Brain Stem/physiopathology , Chemoreceptor Cells/physiology , Disease Models, Animal , Heart/physiopathology , Hypertension/physiopathology , Male , Random Allocation , Rats , Rats, Inbred WKY , Synaptic Transmission , Tissue Culture Techniques
5.
Eur Radiol ; 26(9): 3155-61, 2016 Sep.
Article in English | MEDLINE | ID: mdl-26685851

ABSTRACT

BACKGROUND: We evaluated 18F-FDG PET/CT in small cell lung cancer (SCLC) staging and assessed metabolic (SUVmax, MTV and TLG) and morphologic (CTvol) variables as predictors for overall survival (OS) and progression-free survival (PFS). METHODS: Patients with newly diagnosed, histopathology-confirmed SCLC, who underwent 18F-FDG PET/CT were evaluated. A Cox proportional hazard model was used to determine the association between the primary tumour SUVmax, MTV, TLG and CTvol with OS and PFS. Similar evaluations were performed when hilar/mediastinal lymphadenopathy was included [total SUVmax (TSUVmax), total MTV (TMTV) and total TLG (TTLG)]. RESULTS: 55 patients were included. 18F-FDG PET/CT changed staging in 6/55 (10.9%) patients who were upstaged to extensive disease. TTLG (>443.8) was a significant variable for OS with HR=2.1 (CI 1.14-3.871, p=0.017). Patients with TTLG>443.8 had a median OS of 13.4 months compared to 25.7 months in patients with TTLG<443.8 (p=0.018). TMTV (>72.4) was significant for PFS with HR=2.3 (CI 1.11-4.8, p=0.025). A median PFS of 12.1 and 26.2 months was found with TMTV greater and less than 72.4, respectively (p=0.005). CONCLUSIONS: 18F-FDG PET/CT improved staging of patients with SCLC, and TTLG and TMTV can be used as prognostic variables for OS and PFS, respectively. KEY POINTS: • Identifying variables that predict the prognosis of patients with SCLC is important. • 18F-FDG PET/CT influences staging of patients with SCLC. • Metabolic parameters could be used as predictors for PFS and OS.


Subject(s)
Fluorodeoxyglucose F18/pharmacology , Lung Neoplasms/diagnosis , Neoplasm Staging/methods , Positron Emission Tomography Computed Tomography/methods , Small Cell Lung Carcinoma/diagnosis , Aged , Female , Humans , Male , Middle Aged , Prognosis , Radiopharmaceuticals/pharmacology , Retrospective Studies
6.
Brain Struct Funct ; 220(4): 2103-20, 2015 Jul.
Article in English | MEDLINE | ID: mdl-24793620

ABSTRACT

Coordinated modulation of sympathetic and parasympathetic nervous activity is required for physiological regulation of tissue function. Anatomically, whilst the peripheral sympathetic and parasympathetic pathways are separate, the distribution of premotor neurons in higher brain regions often overlaps. This co-distribution would enable coordinated regulation and might suggest individual premotor neurons could project to both sympathetic and parasympathetic outflows. To investigate this one submandibular gland was sympathectomized. One of two isogenic strains of the pseudorabies virus, expressing different fluorophores, was injected into the cut sympathetic nerve and the other into the submandibular gland. Independent labeling of the peripheral sympathetic and parasympathetic pathways was observed. Dual-labeled neurons were observed in many CNS regions known to be involved in regulating salivary function. We propose these observations highlight a common pattern of organization of the CNS, providing the anatomical framework for the fine control of organ function required for homeostatic regulation and the coordination of organ responses to enable complex behaviors.


Subject(s)
Central Nervous System/cytology , Nerve Net/metabolism , Neurons/physiology , Parasympathetic Nervous System/physiology , Submandibular Gland/physiology , Sympathetic Nervous System/physiology , Animals , Brain Mapping , Herpesvirus 1, Suid/genetics , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Male , Microinjections , Parasympathetic Nervous System/surgery , Rats , Rats, Sprague-Dawley , Sympathetic Nervous System/surgery , Transduction, Genetic , Tyrosine 3-Monooxygenase/metabolism
7.
Aliment Pharmacol Ther ; 40(10): 1146-54, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25263269

ABSTRACT

BACKGROUND: There are differences in the predisposition, natural history of liver disease, complications and treatment response between men and women. AIM: To review clinical differences in cirrhosis between men and women and to address unique management issues of fertility, pregnancy and contraception in this patient population. METHODS: PubMed and MEDLINE were searched using the terms 'cirrhosis' and 'chronic liver disease', each cross-referenced with specific liver diseases, as well as terms such as 'cancer', 'hepatocellular carcinoma', 'smoking', 'liver transplantation', 'metabolic bone disease', 'fertility',' pregnancy' and 'contraception'. RESULTS: Pre-menopausal status is protective in viral hepatitis C and non-alcoholic steatohepatitis. However, smoking, especially in combination with alcohol, is a stronger risk factor for cirrhosis and malignancies in women with chronic liver disease compared to men, although they are less likely than men to develop hepatocellular carcinoma. Women with cirrhosis have more osteopenic bone disease than men and require active management. Successful pregnancy is possible in well-compensated cirrhosis or with mild portal hypertension, although the maternal and foetal mortality and morbidity are higher than in the general population. The maternal risk correlates with liver disease severity and derives mostly from variceal bleeding. The choices for contraception in compensated cirrhosis are generally the same as for the general population. Women with cirrhosis are disadvantaged by the current MELD system of organ allocation, at least in part due to body size. CONCLUSION: The management of women with chronic liver disease is unique in regards to counselling, screening for complications, fertility and pregnancy.


Subject(s)
Liver Diseases , Pregnancy Complications , Disease Management , Esophageal and Gastric Varices/complications , Esophageal and Gastric Varices/therapy , Female , Gastrointestinal Hemorrhage/complications , Gastrointestinal Hemorrhage/therapy , Humans , Liver Diseases/complications , Liver Diseases/therapy , Male , Pregnancy , Pregnancy Complications/therapy
8.
Am J Transplant ; 14(5): 1120-8, 2014 May.
Article in English | MEDLINE | ID: mdl-24731165

ABSTRACT

Use of grafts from donation after circulatory death (DCD) as a strategy to increase the pool of transplantable livers has been limited due to poorer recipient outcomes compared with donation after brain death (DBD). We examined outcomes of recipients of failed DCD grafts who were selected for relisting with regard to waitlist mortality and patient and graft survival after retransplant. From the Scientific Registry of Transplant Recipients database, we identified 1820 adults who underwent first deceased donor liver transplant January 1, 2004 to June 30, 2011, and were relisted due to graft failure; 12.7% were DCD recipients. Compared with DBD recipients, DCD recipients had better waitlist survival (90-day mortality: 8%, DCD recipients; 14-21%, DBD recipients). Of 950 retransplant patients, 14.5% were prior DCD recipients. Graft survival after second liver transplant was similar for prior DCD (28% graft failure within 1 year) and DBD recipients (30%). Patient survival was slightly better for prior DCD (25% death within 1 year) than DBD recipients (28%). Despite higher overall graft failure and morbidity rates, survival of prior DCD recipients who were selected for relisting and retransplant was not worse than survival of DBD recipients.


Subject(s)
Graft Rejection/mortality , Liver Diseases/surgery , Liver Transplantation/mortality , Postoperative Complications , Tissue Donors , Tissue and Organ Procurement/statistics & numerical data , Adult , Death , Female , Follow-Up Studies , Graft Rejection/etiology , Graft Rejection/surgery , Graft Survival , Humans , Liver Diseases/complications , Liver Transplantation/adverse effects , Male , Middle Aged , Prognosis , Reoperation , Risk Factors , Survival Rate , Waiting Lists
9.
J Neurochem ; 119(1): 18-26, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21797869

ABSTRACT

Astrocytes are the major source of angiotensinogen in the brain and play an important role in the brain renin-angiotensin system. Regulating brain angiotensinogen production alters blood pressure and fluid and electrolyte homeostasis. In turn, several physiological and pathological manipulations alter expression of angiotensinogen in brain. Surprisingly, little is known about the factors that regulate astrocytic expression of angiotensinogen. There is evidence that angiotensinogen production in both hepatocytes and cardiac myocytes can be positively regulated via the angiotensin type 1 receptor, but this effect has not yet been studied in astrocytes. Therefore, the aim of this project was to establish whether angiotensin II modulates angiotensinogen production in brain astrocytes. Primary astrocyte cultures, prepared from neonatal C57Bl6 mice, expressed angiotensinogen measured by immunocytochemistry and real-time PCR. Using a variety of approaches we were unable to identify angiotensin receptors on cultured astrocytes. Exposure of cultured astrocytes to angiotensin II also did not affect angiotensinogen expression. When astrocyte cultures were transduced with the angiotensin type 1A receptor, using adenoviral vectors, angiotensin II induced a robust down-regulation (91.4% ± 1.8%, p < 0.01, n = 4) of angiotensinogen gene expression. We conclude that receptors for angiotensin II are present in extremely low levels in astrocytes, and that this concurs with available data in vivo. The signaling pathways activated by the angiotensin type 1A receptor are negatively coupled to angiotensinogen expression and represent a powerful pathway for decreasing expression of this protein, potentially via signaling pathways coupled to Gα(q/11) .


Subject(s)
Angiotensin II/physiology , Angiotensinogen/metabolism , Astrocytes/metabolism , Adenoviridae/genetics , Angiotensin II Type 1 Receptor Blockers/pharmacology , Animals , Astrocytes/drug effects , Benzimidazoles/pharmacology , Biphenyl Compounds , Brain/cytology , Brain Chemistry/physiology , Cells, Cultured , Dexamethasone/pharmacology , Feedback, Physiological , Imidazoles/pharmacology , Immunohistochemistry , Inositol Phosphates/physiology , Liver/drug effects , Liver/metabolism , Mice , Mice, Inbred C57BL , Pyridines/pharmacology , Receptors, Angiotensin/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/physiology , Tetrazoles/pharmacology
10.
Respir Physiol Neurobiol ; 174(1-2): 89-97, 2010 Nov 30.
Article in English | MEDLINE | ID: mdl-20674806

ABSTRACT

Respiratory modulation of autonomic neural activity, with consequent phasic alteration of cardiac and vascular function, has been observed in many species including humans and is considered an index of cardiovascular health. Whilst many factors contribute to this modulation, including for example baroreceptor reflex feedback, it is accepted that a significant component is derived from an interaction within the central nervous system. Functional links between the brainstem circuitry generating the respiratory rhythm and neurons responsible for generate sympathetic and parasympathetic activity to the cardiovascular system have long been hypothesized, although the detailed understanding of these interactions is incomplete. There are several proposed physiological functions for these interactions including the matching of ventilation to cardiac output and tissue blood flow. However, recent observations suggest that altered central respiratory coupling may play a role in the development of hypertension and in the maintenance of elevated levels of sympathetic vasomotor activity in disease. The focus of this review article is to discuss these observations and place them within the context of current understanding of the neural substrates that might be responsible for respiratory-sympathetic coupling.


Subject(s)
Cardiovascular System/physiopathology , Hypertension/etiology , Respiratory System/physiopathology , Sympathetic Nervous System/physiopathology , Animals , Brain Stem/physiology , Brain Stem/physiopathology , Disease Models, Animal , Humans , Neural Pathways/physiopathology , Rats
11.
Ann Oncol ; 21(2): 342-347, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19892746

ABSTRACT

BACKGROUND: Panitumumab has the potential to improve the therapeutic ratio of concurrent chemoradiotherapy for squamous cell carcinoma of the head and neck (SCCHN). PATIENTS AND METHODS: This phase I dose-finding study investigated escalating doses of paclitaxel (Taxol) given concurrently with panitumumab, carboplatin and intensity-modulated radiotherapy (IMRT) for stage III-IVB SCCHN. Untreated patients with oral cavity, oropharynx, larynx, hypopharynx or unknown primaries were eligible. Additional eligibility criteria included measurable disease, good performance status and no contraindication to therapy. Patients received weekly fixed doses of panitumumab and carboplatin plus escalating doses of paclitaxel with IMRT. RESULTS: Nineteen patients were enrolled on to two dose levels (DLs): weekly paclitaxel 15 mg/m(2) (n = 3) and 30 mg/m(2) (n = 16). One dose-limiting toxicity occurred in DL 2, which was declared the maximum tolerated dose. All patients experienced mucositis, primarily grade 3 or more. Oral pain, xerostomia, dysphagia, weight loss, dermatitis, nausea and acneiform rash were frequent. All patients had partial response according to RECIST, whereas the overall complete clinical response rate was 95%. At median follow-up of 21 months, 18 of 19 patients (95%) remained disease free. CONCLUSIONS: Panitumumab, carboplatin, paclitaxel and IMRT are well tolerated and appear highly active in the treatment of SCCHN. Further study of this regimen in SCCHN is warranted.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/radiotherapy , Neoplasms, Squamous Cell/drug therapy , Neoplasms, Squamous Cell/radiotherapy , Adult , Aged , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/adverse effects , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Carboplatin/administration & dosage , Carboplatin/adverse effects , Combined Modality Therapy/adverse effects , Disease Progression , Dose-Response Relationship, Drug , Female , Humans , Male , Maximum Tolerated Dose , Middle Aged , Paclitaxel/administration & dosage , Paclitaxel/adverse effects , Panitumumab , Patient Compliance , Radiotherapy, Intensity-Modulated/adverse effects , Treatment Outcome
12.
Technol Cancer Res Treat ; 7(6): 457-61, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19044325

ABSTRACT

We set out to investigate IMRT-based concomitant boost. Eight patients with stage III/IV squamous cell carcinoma of the head and neck treated with once daily with chemoradiotherapy at the Dana-Farber/Brigham and Women's Hospital had their treatment plans reviewed with IRB approval. Each case was replanned for treatment with a a concomitant boost regimen. Plans delivered 1.9 Gy in 30 fractions to 57 Gy with a boost of 1.5 Gy in 10 fractions for a total dose of 72 Gy. The boost was planned with both IMRT and 3-D conformal, to compare the two techniques. For each patient, both plans (IMRT-IMRT and IMRT-3DCRT) were evaluated for target and avoidance coverage, monitor units and integral dose. Finally, we evaluated the plans for time to completion. The IMRT-IMRT and IMRT-3-DCRT techniques were equivalent for target coverage. 100% coverage of the GTV and PTV was achieved with 97% of the prescription dose. Hot spots were seen 104% to 108% with IMRT-IMRT plan and from 102-111% with the IMRT-3DCRT plans. The IMRT-IMRT boost had double the monitor units as the 3-DCRT boosts. When the total monitor units from both the initial and boost portions of the plans were e combined there was not a significant difference. There was a slight increase in integral dose with the IMRT-IMRT plans of mean 3.8%. Planning time was increased for the 3-DCRT boost as opposed to the IMRT boost (mean 3.5 hours vs. 1.5 hours). More time was needed for quality assurance of the IMRT-IMRT plans (3.0 hours vs. 1.5 hours for IMRT-3-DCRT). We found that both IMRT-based concomitant-boost strategies are achievable and produce good dosimetric results.


Subject(s)
Carcinoma, Squamous Cell/radiotherapy , Dose Fractionation, Radiation , Head and Neck Neoplasms/radiotherapy , Radiotherapy, Intensity-Modulated/methods , Aged , Dose-Response Relationship, Drug , Dose-Response Relationship, Radiation , Female , Humans , Imaging, Three-Dimensional , Male , Middle Aged , Radiometry , Radiotherapy Planning, Computer-Assisted/methods , Radiotherapy, Conformal/methods
13.
Eur J Neurosci ; 28(8): 1536-44, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18973576

ABSTRACT

Vesicular monoamine transporter 2 (VMAT2) packages biogenic amines into large dense core and synaptic vesicles for either somatodendritic or synaptic release from neurons of the CNS. Whilst the distribution of VMAT2 has been well characterized in many catecholaminergic cell groups, its localization amongst C1 adrenergic neurons in the medulla has not been examined in detail. Within the rostral ventrolateral medulla (RVLM), C1 neurons are a group of barosensitive, adrenergic neurons. Rostral C1 cells project to the thoracic spinal cord and are considered sympathetic premotor neurons. The majority of caudal C1 cells project rostrally to regions such as the hypothalamus. The present study sought to quantitate the somatodendritic expression of VMAT2 in C1 neurons, and to assess the subcellular distribution of the transporter. Immunoreactivity for VMAT2 occurred in 31% of C1 soma, with a high proportion of these in the caudal part of the RVLM. Retrograde tracing studies revealed that only two of 43 bulbospinal C1 neurons contained faint VMAT2-immunoreactivity, whilst 88 +/- 5% of rostrally projecting neurons were VMAT2-positive. A lentivirus, designed to express green fluorescent protein exclusively in noradrenergic and adrenergic neurons, was injected into the RVLM to label C1 neurons. Eighty-three percent of C1 efferents that occurred in close proximity to sympathetic preganglionic neurons within the T(3) intermediolateral cell column contained VMAT2-immunoreactivity. These data demonstrate differential distribution of VMAT2 within different subpopulations of C1 neurons and suggest that this might reflect differences in somatodendritic vs. synaptic release of catecholamines.


Subject(s)
Axons/metabolism , Catecholamines/metabolism , Medulla Oblongata/metabolism , Neurons/metabolism , Reticular Formation/metabolism , Vesicular Monoamine Transport Proteins/metabolism , Animals , Autonomic Pathways/cytology , Autonomic Pathways/metabolism , Axonal Transport/physiology , Axons/ultrastructure , Cell Compartmentation/physiology , Genetic Vectors/genetics , Green Fluorescent Proteins/genetics , Immunohistochemistry , Lentivirus/genetics , Male , Medulla Oblongata/cytology , Neurons/cytology , Rats , Rats, Sprague-Dawley , Reticular Formation/cytology , Spinal Cord/cytology , Spinal Cord/metabolism , Sympathetic Nervous System/cytology , Sympathetic Nervous System/metabolism
14.
Brain Res ; 1243: 78-85, 2008 Dec 03.
Article in English | MEDLINE | ID: mdl-18840419

ABSTRACT

Renin plays a critical role in fluid and electrolyte homeostasis by cleaving angiotensinogen to produce Ang peptides. Whilst it has been demonstrated that renin mRNA is expressed in the brain, the distribution of cells responsible for this expression remains uncertain. We have used a transgenic mouse approach in an attempt to address this question. A transgenic mouse, in which a 12.2 kb fragment of the human renin promoter was used to drive expression of Cre-recombinase, was crossed with the ROSA26-lac Z reporter mouse strain. Cre-recombinase mediated excision of the floxed stop cassette resulted in expression of the reporter protein, beta-galactosidase. This study describes the distribution of beta-galactosidase in the brain of the crossed transgenic mouse. In all cases where it was examined the reporter protein was co-localized with the neuronal marker NeuN. An extensive distribution was observed with numerous cells labeled in the somatosensory, insular, piriform and retrosplenial cortices. The motor cortex was devoid of labeled cells. Several other regions were labeled including the parts of the amygdala, periaqueductal gray, lateral parabrachial nucleus and deep cerebellar nuclei. Overall the distribution shows little overlap with those regions that are known to express receptors for the renin-angiotensin system in the adult brain. This transgenic approach, which demonstrates the distribution of cells which have activated the human renin promoter at any time throughout development, yields a unique and extensive distribution of putative renin-expressing neurons. Our observations suggest that renin may have broader actions in the brain and may indicate a potential for interaction with the (pro)renin receptor or production of a ligand for non-AT(1)/AT(2) receptors.


Subject(s)
Brain/metabolism , Neurons/metabolism , Promoter Regions, Genetic/genetics , Renin/genetics , Renin/metabolism , beta-Galactosidase/genetics , Animals , Brain/cytology , Brain Mapping , DNA-Binding Proteins , Gene Expression Regulation/genetics , Genes, Reporter/genetics , Humans , Lac Operon/genetics , Mice , Mice, Transgenic , Molecular Biology/methods , Nerve Tissue Proteins/metabolism , Neurons/cytology , Nuclear Proteins/metabolism , Receptors, Angiotensin/metabolism , Renin-Angiotensin System/genetics , beta-Galactosidase/metabolism
15.
Eur J Neurosci ; 25(8): 2404-12, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17445237

ABSTRACT

The concept of 'command neurons', whereby single neurons mediate complex and complementary motor functions to generate a stereotyped behaviour, is well developed in invertebrate physiology. The term has also been adopted more recently to explain the neural basis of 'fight or flight'. In this study we have investigated the possibility that single lateral hypothalamic neurons have the necessary neuroanatomical connections to coordinate two complementary limbs of body weight control, feeding and thermogenesis, thereby acting as 'command neurons'. The transynaptic retrograde transport of pseudorabies virus (Bartha) from a thermogenic endpoint in the brown adipose tissue of rats has been used in conjunction with other neuronal tracers, introduced into putative CNS feeding centres, to assess the potential for the involvement of command neurons in coordinating these processes. In discrete regions of the lateral hypothalamus, neurons have been identified which have the necessary complement of orexigenic peptides and collateral branching axons to both putative feeding sites and thermogenic sites in brown fat to qualify as candidate central command neurons controlling body weight.


Subject(s)
Brain Mapping , Feeding Behavior/physiology , Hypothalamic Area, Lateral/cytology , Neural Pathways , Neurons/metabolism , Thermogenesis/physiology , Adipose Tissue, Brown/anatomy & histology , Animals , Fluorescent Dyes/metabolism , Herpesvirus 1, Suid/metabolism , Hypothalamic Hormones/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Male , Medulla Oblongata/cytology , Medulla Oblongata/metabolism , Melanins/metabolism , Nerve Tissue Proteins/metabolism , Neural Pathways/anatomy & histology , Neural Pathways/physiology , Neurons/cytology , Neuropeptides/metabolism , Orexins , Pituitary Hormones/metabolism , Rats , Rats, Sprague-Dawley , Staining and Labeling
16.
Cell Tissue Res ; 324(1): 9-16, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16418838

ABSTRACT

The sympathetic innervation of the rat heart was investigated by retrograde neuronal tracing and multiple label immunohistochemistry. Injections of Fast Blue made into the left ventricular wall labelled sympathetic neurons that were located along the medial border of both the left and right stellate ganglia. Cardiac projecting sympathetic postganglionic neurons could be grouped into one of four neurochemical populations, characterised by their content of calbindin and/or neuropeptide Y (NPY). The subpopulations of neurons contained immunoreactivity to both calbindin and NPY, immunoreactivity to calbindin only, immunoreactivity to NPY only and no immunoreactivity to calbindin or NPY. Sympathetic postganglionic neurons were also labelled in vitro with rhodamine dextran applied to the cut end of a cardiac nerve. The same neurochemical subpopulations of sympathetic neurons were identified by using this technique but in different proportions to those labelled from the left ventricle. Preganglionic terminals that were immunoreactive for another calcium-binding protein, calretinin, preferentially surrounded retrogradely labelled neurons that were immunoreactive for both calbindin and NPY. The separate sympathetic pathways projecting to the rat heart may control different cardiac functions.


Subject(s)
Heart Ventricles/innervation , Neurons/chemistry , Sympathetic Fibers, Postganglionic/physiology , Amidines/administration & dosage , Animals , Calbindin 2 , Calbindins , Female , Ganglia, Sympathetic/cytology , Ganglia, Sympathetic/metabolism , Immunohistochemistry , Male , Neurons/classification , Neuropeptide Y/metabolism , Rats , Rats, Sprague-Dawley , S100 Calcium Binding Protein G/metabolism , Staining and Labeling/methods , Stellate Ganglion/metabolism , Tyrosine 3-Monooxygenase/metabolism
17.
Am J Physiol Regul Integr Comp Physiol ; 287(4): R824-32, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15205184

ABSTRACT

The dorsomedial hypothalamic nucleus (DMH) is believed to play a key role in mediating vasomotor and cardiac responses evoked by an acute stress. Inhibition of neurons in the rostral ventrolateral medulla (RVLM) greatly reduces the increase in renal sympathetic nerve activity (RSNA) evoked by activation of the DMH, indicating that RVLM neurons mediate, at least in part, the vasomotor component of the DMH-evoked response. In this study, the first aim was to determine whether neurons in the medullary raphe pallidus (RP) region also contribute to the DMH-evoked vasomotor response, because it has been shown that the DMH-evoked tachycardia is mediated by the RP region. The second aim was to directly assess the effect of DMH activation on the firing rate of RVLM sympathetic premotor neurons. In urethane-anesthetized rats, injection of the GABA(A) receptor agonist muscimol (but not vehicle solution) in the RP region caused a modest ( approximately 25%) but significant reduction in the increase in RSNA evoked by DMH disinhibition (by microinjection of bicuculline). In other experiments, disinhibition of the DMH resulted in a powerful excitation (increase in firing rate of approximately 400%) of 5 out of 6 spinally projecting barosensitive neurons in the RVLM. The results indicate that neurons in the RP region make a modest contribution to the renal sympathoexcitatory response evoked from the DMH and also that sympathetic premotor neurons in the RVLM receive strong excitatory inputs from DMH neurons, consistent with the view that the RVLM plays a key role in mediating sympathetic vasomotor responses arising from the DMH.


Subject(s)
Dorsomedial Hypothalamic Nucleus/physiology , Medulla Oblongata/physiology , Raphe Nuclei/physiology , Animals , Bicuculline/pharmacology , Blood Pressure/drug effects , Dorsomedial Hypothalamic Nucleus/cytology , Dose-Response Relationship, Drug , Electric Stimulation , GABA Agonists/pharmacology , GABA Antagonists/pharmacology , Heart Rate/drug effects , Kidney/drug effects , Kidney/innervation , Male , Medulla Oblongata/cytology , Microinjections , Muscimol/pharmacology , Neural Pathways/cytology , Neural Pathways/drug effects , Neural Pathways/physiology , Neurons/drug effects , Neurons/physiology , Raphe Nuclei/cytology , Rats , Rats, Sprague-Dawley , Stereotaxic Techniques
18.
Phys Rev Lett ; 92(10): 102003, 2004 Mar 12.
Article in English | MEDLINE | ID: mdl-15089200

ABSTRACT

We report on a new measurement of the parity-violating asymmetry in quasielastic electron scattering from the deuteron at backward angles at Q2=0.038 (GeV/c)2. This quantity provides a determination of the neutral weak axial vector form factor of the nucleon, which can potentially receive large electroweak corrections. The measured asymmetry A=-3.51+/-0.57 (stat)+/-0.58 (syst) ppm is consistent with theoretical predictions. We also report on updated results of the previous experiment at Q2=0.091 (GeV/c)2, which are also consistent with theoretical predictions.

19.
Neuroscience ; 124(2): 341-9, 2004.
Article in English | MEDLINE | ID: mdl-14980384

ABSTRACT

Central administration of angiotensin IV (Ang IV) or its analogues enhance performance of rats in passive avoidance and spatial memory paradigms. The purpose of this study was to examine the effect of a single bolus injection of two distinct AT4 ligands, Nle1-Ang IV or LVV-haemorphin-7, on spatial learning in the Barnes circular maze. Mean number of days for rats treated with either Nle1-Ang IV or LVV-haemorphin-7 to achieve learner criterion is significantly reduced compared with controls (P < 0.001 and P < 0.05 respectively). This is due to enhanced ability of the peptide-treated rats to adopt a spatial strategy for finding the escape hatch. In all three measures of learning performance, (1) the number of errors made, (2) the distance travelled and (3) the latency in finding the escape hatch, rats treated with either 100 pmol or 1 nmol of Nle1-Ang IV or 100 pmol LVV-haemorphin-7 performed significantly better than the control groups. As early as the first day of testing, the rats treated with the lower dose of Nle1-Ang IV or LVV-haemorphin-7 made fewer errors (P < 0.01 and P < 0.05 respectively) and travelled shorter distances (P < 0.05 for both groups) than the control animals. The enhanced spatial learning induced by Nle1-Ang IV (100 pmol) was attenuated by the co-administration of the AT4 receptor antagonist, divalinal-Ang IV (10 nmol). Thus, administration of AT4 ligands results in an immediate potentiation of learning, which may be associated with facilitation of synaptic transmission and/or enhancement of acetylcholine release.


Subject(s)
Angiotensin II/analogs & derivatives , Angiotensin Receptor Antagonists , Hemoglobins/pharmacology , Learning/drug effects , Oligopeptides/pharmacology , Peptide Fragments/pharmacology , Spatial Behavior/drug effects , Angiotensin II/pharmacology , Animals , Avoidance Learning/drug effects , Behavior, Animal , Injections, Intraventricular/methods , Male , Rats , Rats, Sprague-Dawley , Reaction Time/drug effects , Receptors, Angiotensin , Time Factors
20.
J Neuroendocrinol ; 15(10): 907-15, 2003 Oct.
Article in English | MEDLINE | ID: mdl-12969234

ABSTRACT

This study examined the role of the diagonal band of Broca (DBB) in drinking behaviour and vasopressin release. Adult male rats were anaesthetized (pentobarbital 50 mg/kg) and received DBB injections of either ibotenic acid (0.5 microl of 5 micro g/ microl) or vehicle (0.5 microl of phosphate-buffered saline). Although baseline drinking and urine output were not affected, drinking to 30% polyethylene glycol (MW 8000; 1 ml/100 g s.c.) and angiotensin II (0, 1.5 and 3.0 mg/kg s.c.) were significantly increased in ibotenic acid in phosphate-buffered saline (DBBX) rats. Drinking to hypertonic saline (0.9, 4 and 6%; 1 ml/100 g), and water deprivation were not significantly affected. DBBX rats had significantly lower basal heart rates than controls but the cardiovascular responses to infusions of angiotensin II (100 ng/kg/min i.v. for 45 min) were not affected. DBBX rats had significantly higher basal vasopressin, but angiotensin-stimulated vasopressin release was not significantly different. Although the DBB is not involved in basal water intake, it is involved in dipsogenic responses to hypovolemic stimuli and possibly basal autonomic function and basal vasopressin release.


Subject(s)
Diagonal Band of Broca/physiology , Drinking/physiology , Angiotensin II/pharmacology , Animals , Blood Pressure/physiology , Body Weight/drug effects , Body Weight/physiology , Diagonal Band of Broca/drug effects , Diagonal Band of Broca/metabolism , Eating/physiology , Excitatory Amino Acid Agonists/toxicity , Heart Rate/physiology , Hypertonic Solutions/pharmacology , Ibotenic Acid/toxicity , Image Processing, Computer-Assisted , Male , Polyethylene Glycols/pharmacology , Rats , Rats, Long-Evans , Vasopressins/metabolism , Water Deprivation/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...